← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2009Last known activity
Jul 30, 2025
Acquired by Biontech on Jun 12, 2025
Timeline
2000s
- Jun 1, 2000
CureVac AG— Founded
2020s
- Jun 12, 2025
Biontech— Acquired By
Drugs by trial phase (22 distinct, 26 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Recent trials (28)
- NCT07073183Lead sponsorPhase 1Jul 30, 2025
- NCT07073183OfficialPhase 1Jul 30, 2025
- NCT05960097CollaboratorPhase 2Aug 1, 2023
- NCT05938387Lead sponsorPhase 1May 9, 2023
- NCT05938387OfficialPhase 1May 9, 2023
- NCT05823974CollaboratorPhase 1/Phase 2Apr 27, 2023
- NCT05446740CollaboratorPhase 1Aug 9, 2022
- NCT05260437CollaboratorPhase 1Mar 24, 2022
- NCT05252338Lead sponsorPhase 1Feb 7, 2022
- NCT04848467CollaboratorPhase 3Oct 1, 2021
- NCT04838847Lead sponsorPhase 3Oct 1, 2021
- NCT04860258Lead sponsorPhase 3Apr 22, 2021
- NCT04674189Lead sponsorPhase 3Dec 16, 2020
- NCT04652102Lead sponsorPhase 2/Phase 3Dec 14, 2020
- NCT04515147Lead sponsorPhase 2Sep 28, 2020
Details
- Founded
- Tubingen, DE Jun 1, 2000
- Last known activity
- Jul 30, 2025